Indaptus Therapeutics, Inc. - 8-K Filing

Indaptus Therapeutics raised $24M via private placement at a discount to its Nasdaq price for R&D and corporate purposes (Items: 1.01 Entry into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $INDP

Read the full article at SEC EDGAR

More Regulatory news